If you have regular treatments, you will notice an improvement in how quickly you can shed fat and lose weight over the course of several months
Millions of people taking GLP-1 medications such as Ozempic, Wegovy, and semaglutide are learning how to navigate restaurant menus differently
Moreover, estimating risks based on BMI changes can additionally reflect changes in risk due to on changes in triglycerides and inflammatory factors such as c-reactive protein, which are significantly impacted by semaglutide treatment
Unpublished studies have also demonstrated that the IGF-1Rs of PPP treated cells are undergoing rapid downregulation
GLP-1 therapies are moving beyond diabetes and obesity into MASH/NAFLD, cardiovascular risk reduction, and possibly neurodegenerative conditions
And institutional investors, quite frankly, which is why stocks have done so much better